Takeda Pharmaceuticals reaches $2bn deal to develop Alzheimer’s vaccine

By Financial Times
| May 13, 2024

Japanese pharma group takes on new jab that makes immune system attack dangerous protein build-up in brain

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...